InvestorsHub Logo
Followers 27
Posts 675
Boards Moderated 0
Alias Born 07/26/2017

Re: None

Tuesday, 03/13/2018 1:18:16 PM

Tuesday, March 13, 2018 1:18:16 PM

Post# of 699230
Here is a post on the Yahoo message board from Meifud a known fudster.
He references knowledge of the publication and the journal.
This is most likely lies but let's see what comes up in the next week or two.

meifud yesterday
publication will be in the Journal of Cancer Research and Clinical Oncology, and will share how the trial was designed, how patients were screened, how pseudoprogression diagnosis has been complicated by reaction to the vaccine, why the trial was redesigned and expanded, etc., and a lot of numbers from a year ago will appear again but with the caveat that comparison with the average survival of GBM patients has to factor in the screening criteria applied to phase III enrollees that was not applied to the general population of GBM patients
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News